Norepinephrine releasing agent

From WikiMD.com Medical Encyclopedia

Norepinephrine Releasing Agent[edit | edit source]

Chemical structure of Ephedrine, a norepinephrine releasing agent.

A norepinephrine releasing agent (NRA) is a type of drug that induces the release of norepinephrine (also known as noradrenaline) from the presynaptic neuron into the synaptic cleft, thereby increasing the concentration of norepinephrine in the synapse. This action enhances the activity of the sympathetic nervous system, leading to various physiological effects.

Mechanism of Action[edit | edit source]

Norepinephrine releasing agents primarily act by entering the presynaptic neuron and promoting the release of norepinephrine stored in synaptic vesicles. This process often involves the reversal of the norepinephrine transporter (NET), which normally functions to reuptake norepinephrine from the synaptic cleft back into the neuron. By reversing this transporter, NRAs increase the extracellular concentration of norepinephrine, thereby enhancing adrenergic signaling.

Pharmacological Effects[edit | edit source]

The increase in norepinephrine levels due to NRAs leads to stimulation of adrenergic receptors throughout the body. This can result in:

These effects make NRAs useful in the treatment of conditions such as hypotension, narcolepsy, and attention deficit hyperactivity disorder (ADHD).

Examples of Norepinephrine Releasing Agents[edit | edit source]

One of the most well-known norepinephrine releasing agents is ephedrine, a naturally occurring compound found in plants of the genus Ephedra. Ephedrine is used both as a medication and as a stimulant. It is commonly used to prevent low blood pressure during spinal anesthesia, as a bronchodilator in asthma, and as a weight loss aid.

Clinical Uses[edit | edit source]

Norepinephrine releasing agents are used in various clinical settings:

  • Hypotension: NRAs can be used to treat low blood pressure, especially during surgical procedures.
  • Asthma and COPD: Due to their bronchodilatory effects, NRAs like ephedrine are used in the management of asthma and chronic obstructive pulmonary disease (COPD).
  • Weight Loss: Some NRAs are used as appetite suppressants in weight loss programs.

Side Effects[edit | edit source]

The use of norepinephrine releasing agents can lead to several side effects, including:

These side effects are primarily due to the excessive stimulation of the sympathetic nervous system.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD